5. Straub R. H., Lehle K., Herfarth H., Weber M., Falk M. W., Preuner J., Scholmerich J. (2002) Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: Role of interleukin-6 and tumour necrosis factor // Eur J. Endo 146: 365–374.
6. National Sleep Foundation, “Epidemic of Daytime Sleepiness Linked to Increased Feelings of Anger, Stress, and Pessimism,” sleepfoundation.org/site/c.huIXKjM0IxF/b.2417359/k.3028/Epidemic_of_Daytime_Sleepiness_Linked_to_ Increased_Feelings_of_Anger_Stress_and_Pessimism.htm.
7. Leger D., Laudon M., Zisapel N. (2004) Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy // Am. J. Med. 116:91–95.
8. The Writing Group for the WHI Investigators (2002) Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results of the Women’s Health Initiative randomized controlled trial // JAMA 288 (3): 321–333.
9. The Women’s Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative randomized controlled trial // JAMA 291: 1701–1712.
10. Rossouw J. E., Prentice R. L., Manson J. E., Wu L., Barad D., Barnabei V. M., Ko M., LaCroix A. Z., et al. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause // JAMA 297: 1465–1477.
11. Fournier A., Berrino F., Riboli E., Avenel V., and Clavel-Chapelon F. (2005). Риск развития рака молочной железы в связи с различными видами заместительной гормональной терапии в когорте E3N-EPIC // Проблемы репродукции. М.: Медиа Сфера, № 4 (2005).
12. Rudman D., Drinka P. J., Wilson C. R., Mattson D. E., Scherman F., Cuisinier M. C., Schultz S. (1994) Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men // Clin Endo 40: 653–661.
13. Stephenson K., Price C., Kurdowska A., Neuenschwander P., Stephenson J., Pinson B., Stephenson D., Alfred D., Krupa A., Mahoney D., Zava D., and Bevan M. (2004) Topical progesterone cream does not increase thrombotic and inflammatory factors in postmenopausal women // ASH Annual Meeting Abstracts 104: 5318.
Глава 5. Метаболические процессы
1. Das UN (2006) Exercise and inflammation // The Euro Heart J. 27 (11): 1385.
2. Fenech M., Aitken C., Rinaldi J. (1998) Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults // Carcinogenesis 19 (7): 1163–1171.
Глава 6. Онкологические заболевания
1. American Cancer Society, “Cancer Facts and Figures,” cancer.org/docroot/stt/stt_0.asp.
2. American Cancer Society, “Costs of Cancer,” cancer.org/docroot/MIT/content/MIT_3_2X_Costs_of_Cancer.asp.
3. Key T. J., Schatzkin A., Willett W. C., Allen N. E., Spencer E. A., Travis R. C. (2004) Diet, nutrition and the prevention of cancer // Pub Health Nutr Feb 7 (1A): 187–200.
4. Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. (2003) Adherence to a Mediterranean diet and survival in a Greek population // N Engl J. Med 348 (26): 2599–2608.
5. Dominique M. S., Simin L., Giovannucci E., Willett W. C., Graham C. A., Fuchs C. S. (2002) Dietary sugar, glycemic load and pancreatic cancer risk in a prospective study // Natl Can Jnsf 94 (17): 1293–1300.
6. Higginbotham S., Zhang Z. F., Lee I. M., Cook N., Giovannucci E., Buring J. E., Liu S. (2004) Dietary glycemic load and risk of colorectal cancer in the Women’s Health Study // Natl Can Inst 96 (3): 229–233.
7. Calle E. E., Rodrigue C., Walker-Thurmond K., Thun M. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults // NEJM 348 (17): 1625–1638.
8. Zheng Q. S., Zheng R. L. (2002) Effects of ascorbic acid and sodium selenite on growth and redifferentiation in human hepatoma cells and its mechanisms // Pharmazie 57 (4): 265–269.
9. Duffield-Lillico A. J., Reid M. E., Turnbull B. W., Combs G. F., Slate E. H., Fischbach L. A., Marshall J. R., Clark L. C. (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial // Cancer Epidemiol Biomarkers Prev 11: 630–639.
